Michael Robert Martin - Nov 7, 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Business Officer
Signature
/s/ Michael Robert Martin
Stock symbol
AUPH
Transactions as of
Nov 7, 2022
Transactions value $
$154,800
Form type
4
Date filed
11/9/2022, 03:05 PM
Previous filing
Mar 4, 2022
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Purchase $155K +30K +50.41% $5.16 89.5K Nov 7, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.98 to $5.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.